ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 97 filers reported holding PIERIS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$56,000
-96.0%
18,200
-95.7%
0.00%
-100.0%
Q1 2019$1,407,000
-12.8%
420,130
-30.7%
0.00%
-25.0%
Q4 2018$1,613,000
-66.8%
606,295
-30.1%
0.00%
-63.6%
Q3 2018$4,860,000
-5.8%
867,855
-14.7%
0.01%
-15.4%
Q2 2018$5,161,000
-26.5%
1,017,890
-1.2%
0.01%
-18.8%
Q1 2018$7,023,000
+108.4%
1,029,798
+130.7%
0.02%
+100.0%
Q4 2017$3,370,000446,3710.01%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 9,775,849$2,913,2031.93%
Aquilo Capital Management, LLC 3,303,190$984,3510.89%
CM Management, LLC 649,400$193,5210.20%
BVF INC/IL 20,609,863$6,141,7390.17%
WEALTH EFFECTS LLC 11,700$3,4870.00%
NJ State Employees Deferred Compensation Plan 30,000$8,9400.00%
HUDSON VALLEY INVESTMENT ADVISORS INC /ADV 14,000$4,1720.00%
ACADIAN ASSET MANAGEMENT LLC 962,358$2860.00%
TWO SIGMA ADVISERS, LP 24,400$7,2710.00%
Tower View Wealth Management LLC 1,000$00.00%
View complete list of PIERIS PHARMACEUTICALS INC shareholders